Skip to content

The efficacy and safety of postoperative pain control using combination analgesic of Acetaminophen and Ibuprofen in breast cancer surgery

The efficacy and safety of postoperative pain control using combination analgesic of Acetaminophen and Ibuprofen in breast cancer surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0010462
Enrollment
144
Registered
2025-05-08
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The inclusion and exclusion criteria, if you are selected as a suitable participant for this clinical trial, you will be randomly assigned to either the experimental group or the active compara

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.participant scheduled for breast reconstruction with deep inferior epigastric perforator flap. 2.participant aged 20years or older and under 65. 3.participant classified as physical status I-III according to the American Society of Anesthesiologists (ASA) classification.

Exclusion criteria

Exclusion criteria: 1. Allergic reactions or clinically significant hypersensitivity to drugs such as acetaminophen, ibuprofen, aspirin, opioid analgesics, or any non - steroidal anti - inflammatory drugs ( NSAIDs ) 2. Chronic pain requiring long - term use of opioid analgesics 3. Other severe pain unrelated to the target disease, which could confuse the pain assessment during the screening process 4. History of previous non - minor surgeries related to cancer diagnosis ( Minor surgeries include : appendectomy, chalecystectomy. hernia surgery. etc. ) 5. Liver dysfunction : Elevated AST. ALT levels (> 40 IU / L ) n pre - surgery tests, severe liver disease, liver cirrhosis, or a history of these conditions 6. Renal dysfunction : Estimated glomerular filtration rate ( eGFR ) N 60 ml / min as calculated by the CKD - EPI formula based on pre - surgery blood tests, chronic kidney disease ( CKD ), or end - stage renal disease ( Cr > 1.6 mg / dL ) 7. Use of certain medications : Patients taking barbiturates or tricyclic antidepressants 8. Non - consent : Patients who do not consent to participate In the study 9. Judgment by the investigator or research staff that the patient is not appropriate for inclusion in the clinical trial

Design outcomes

Primary

MeasureTime frame
Pain changes before surgery, on the day of surgery, and during the 4 days post-surgery. The difference between the maximum pain score over 4 days and the pain score on the day of surgery. The maximum pain score refers to the highest value recorded on the NRS pain scale. Numeric Pain Rating Scale (NRS): (0 = no pain, 10 = worst possible pain)

Secondary

MeasureTime frame
Total amount of opioid analgesics administered as rescue medication within 72 hours after surgery.Total amount of intravenous fentanyl used within 3 days after surgery,Incidence of complications such as postoperative nausea and vomiting (PONV) starting from day 2 after surgery,Time of first opioid analgesic rescue medication use within 72 hours after surgery ,Frequency of patient's additional analgesic requests within 4 days after surgery,lab test results on the 3rd day after surgery: AST/ALT, BUN/Creatinine;Adverse reactions during the 4 days after surgery(nausea, vomiting, itching, drowsiness, constipation, diaphoresis, loss of appetite, facial flushing, injection site pain)

Countries

Korea, Republic of

Contacts

Public ContactJin Supp Um

Asan Medical Center

jinsupp@amc.seoul.kr+82-2-3010-3602

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026